Entry Rationale
The current price of $13.36 is positioned between 12.07 (support) and 15.75 (resistance). Given its proximity to the support level and the potential for a rebound, a buy decision is being considered.
V12 SENTINEL ENGINE
All AI Trading Journal Entries
SMMTAI Trading Journal · 2026-09-04
Surges 28% on Expectations of New Drug Clinical Trial Success, Exceeding Forecast
Summit rises as lead drug from Akeso outperforms Astra’s Imfinzi in late-stage trial
ENTRY PRICE$13.36Entry reference price
AI PREDICTION+2.5%Predicted upside
VERIFIED RESULT28.2%28.2% up
PREDICTION GAP+25.7%pGap vs. actual result
CONFIDENCE85AI analysis confidence
The report states that Summit's key new drug, which serves as Akeso's lead drug, outperformed Astra's Imfinzi in a late-stage clinical trial.
02
INITIAL SCENARIO
AI's Initial Call
Target/Stop Scenario
If the stock price reaches the resistance level of 15.75, take profits at $15.75; if it falls below the support level of 12.07, cut losses at $12.07. As the current price is $13.36, a rebound near the support level is expected.
Take-profit reference$15.75
Stop-loss reference$12.07
03
TECHNICAL BASELINE
Market Data at Analysis Time
MA20$13.5MA60$14.13MA200$16.54
RSI(14) 48.7 (neutral), moving averages not in bullish alignment (trend not established), trading volume at 1.28x the 20-day average (rising volume), 7-day price change +0.1% (almost no price movement).
04
HISTORICAL EVIDENCE
Similar Past Cases
The SMMT (2026-09-04) case, which overlapped on the same ticker, the same news, and the keyword 'ivonescimab', recorded a 28.2% return and shares the same catalyst and price range as the current trade. Although the VEEE (2026-07-16) and LRCX (2026-07-06) cases show no direct similarity, their high returns of 451.7% and 346.8%, respectively, can be referenced as an indication of the potential for high returns.
Reviewing Prediction vs. Actual Result
Compared to the predicted return of 2.5%, the actual return came in at 28.2%, resulting in an OVERHIT outcome. The entry decision based on news and support/resistance levels was accurate, but the gap stemmed from a significant underestimation of the magnitude of the rally.
What to Watch in the Next Analysis
In the next trade, the same catalyst effect and price range will be utilized, while the target return will be adjusted upward to a more realistic level, and the position size will be increased if upward momentum is strong. In addition, trading volume surges and RSI changes will be monitored more closely to optimize the entry timing.
05
V13 VERIFICATION
V13 Worker auto-verifiedChart Verification
Initial ChartAt Analysis · 2026-09-04
$13.36Verification ChartVerification · 2026-09-04 11:48:28
28.2%Investment Reference NoticeThis report is a record of past AI analysis being verified — it does not solicit buying or selling any specific stock. All investment decisions and responsibility rest with the user.